EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Comparing hypertrophy of the future liver remnant for two different strategies of portal vein embolization in patients with bilobar colorectal liver metastases – a retrospective European multicentre study

Dennis Björk, Tim Reese, Anne M Holmen Longva, Kristian S Kiim, Maximilian Evers, Peter N Larsen, Nicolai Aagaard Schultz, Bård I Røsok, Ulrik Carling, Fredrik Holmquist, Gert Lindell, Per Sandström und 7 weitere

HPB · 2026

DOI: 10.1016/j.hpb.2025.12.006 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift HPB, 2026. Verfasst von Dennis Björk und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Electronic address: d…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Embolization, Therapeutic, Hepatectomy, Liver Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Portal vein embolization (PVE) is a well-established technique for inducing liver hypertrophy in the future liver remnant (FLR) before major hepatectomy. A frequently used method in bilobar disease is the two-stage hepatectomy (TSH) technique combined with PVE (TSH-PVE). A novel approach is PVE, followed by a one-stage hepatectomy (OSH), combining major hepatectomy with clearing of the FLR (PVE-OSH). This study aimed to compare FLR hypertrophy between these two strategies for induced liver hypertrophy. MATERIAL/METHODS: Patients with bilobar colorectal liver metastases (CRLM) who underwent PVE from January 2013 to December 2021 were included in this retrospective, multicenter study. Aspects of hypertrophy of the FLR were compared between the groups. RESULTS: The study included 188 patients, 127 in the PVE-OSH group and 61 in the TSH-PVE group. There were no statistically significant differences between the two groups regarding FLR hypertrophy measured by absolute and relative growth, degree of hypertrophy or kinetic growth rate. No major complications were reported. DISCUSSION/CONCLUSION: No differences in FLR hypertrophy were demonstrated between the two different treatment strategies of TSH-PVE or PVE-OSH. This supports PVE-OSH as a feasible treatment option that reduces the surgical burden for patients with advanced, bilobar CRLM disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEmbolization, TherapeuticHepatectomyLiver NeoplasmsPortal VeinLiverHumansRetrospective StudiesMaleFemaleMiddle AgedAgedHypertrophyTreatment OutcomeEurope

Autor:innen und Institutionen

  • Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Electronic address: dennis.bjork@liu.se.
  • Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway.
  • Department of Surgical Gastroenterology and Transplantation, Rigshospitalet, University of Copenhagen, Denmark.
  • Department of Radiology, Rigshospitalet, Oslo University Hospital, Oslo, Norway.
  • Department of Surgery, Skåne University Hospital, Lund, Sweden.

Zitieren

APA

Björk, D., Reese, T., Holmen Longva, A. M., Kiim, K. S., Evers, M., Larsen, P. N., Aagaard Schultz, N., Røsok, B. I., Carling, U., Holmquist, F., Lindell, G., Sandström, P., Böcker, J., Gilg, S., Engstrand, J., Sturesson, C., Oldhafer, K. J., Sparrelid, E., & Björnsson, B. (2026). Comparing hypertrophy of the future liver remnant for two different strategies of portal vein embolization in patients with bilobar colorectal liver metastases – a retrospective European multicentre study. HPB. https://doi.org/10.1016/j.hpb.2025.12.006

Vancouver

Björk D, Reese T, Holmen Longva AM, Kiim KS, Evers M, Larsen PN, et al. Comparing hypertrophy of the future liver remnant for two different strategies of portal vein embolization in patients with bilobar colorectal liver metastases – a retrospective European multicentre study. HPB. 2026. doi:10.1016/j.hpb.2025.12.006

BibTeX
@article{Bjrk2026,
  author = {Björk, Dennis and Reese, Tim and Holmen Longva, Anne M and Kiim, Kristian S and Evers, Maximilian and Larsen, Peter N and Aagaard Schultz, Nicolai and Røsok, Bård I and Carling, Ulrik and Holmquist, Fredrik and Lindell, Gert and Sandström, Per and Böcker, Jörg and Gilg, Stefan and Engstrand, Jennie and Sturesson, Christian and Oldhafer, Karl J and Sparrelid, Ernesto and Björnsson, Bergthor},
  title = {Comparing hypertrophy of the future liver remnant for two different strategies of portal vein embolization in patients with bilobar colorectal liver metastases – a retrospective European multicentre study},
  journal = {HPB},
  year = {2026},
  doi = {10.1016/j.hpb.2025.12.006}
}
Kostenlos starten →